ponatinib

tumor necrosis factor ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31444999 Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma. 2019 Oct 2
2 25801024 Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. 2015 Mar 24 2
3 25996294 A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. 2015 May 21 1